Similarly, the Scgb1a1 mRNA levels were lower in the BLM-treated groups than in the PBS control mice, while there was no difference observed between Scgb3a2-null and wild-type mice for both BLM treated and control groups. This evidence concerns the gene SCGB1A1 and Bloom syndrome.